Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate

被引：9

作者：

Wang, Xiaoli ^{[1
]}

Wang, Jiao ^{[2
]}

Zhang, Wenmei ^{[1
]}

Li, Boye ^{[1
]}

Zhu, Ying ^{[1
]}

Hu, Qin ^{[1
]}

Yang, Yishu ^{[1
]}

Zhang, Xiaoguang ^{[2
]}

Yan, Hong ^{[1
]}

Zeng, Yi ^{[2
]}

机构：

[1] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China

[2] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China

来源：

VIRUSES-BASEL | 2018年 / 10卷 / 05期

基金：

中国国家自然科学基金;

关键词：

human immunodeficiency virus type 1; Keggin polyoxometalate; entry inhibition; CD4; gp41; NHR; IN-VITRO; HIV-1; ENTRY; ANTIVIRAL ACTIVITY; REVERSE-TRANSCRIPTASE; ANTI-HIV-1; AGENTS; MULTIPLE STEPS; VIVO; REPLICATION; HPA-23; ASSAY;

D O I：

10.3390/v10050265

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Here, we report the anti-human immunodeficiency virus (HIV) potency and underlying mechanisms of a Keggin polyoxometalate (PT-1, K6HPTi2W10O40). Our findings showed that PT-1 exhibited highly potent effects against a diverse group of HIV type 1 (HIV-1) strains and displayed low cytotoxicity and genotoxicity. The time-addition assay revealed that PT-1 acted at an early stage of infection, and these findings were supported by the observation that PT-1 had more potency against Env-pseudotyped virus than vesicular stomatitis virus glycoprotein (VSVG) pseudotyped virus. Surface plasmon resonance binding assays and flow cytometry analysis showed that PT-1 blocked the gp120 binding site in the CD4 receptor. Moreover, PT-1 bound directly to gp41 NHR (N36 peptide), thereby interrupting the core bundle formation of gp41. In conclusion, our data suggested that PT-1 may be developed as a new anti-HIV-1 agent through its effects on entry inhibition.

引用

页数：15

共 48 条

[11] Prevention of the interaction between HVEM, herpes virus entry mediator, and gD, HSV envelope protein, by a Keggin polyoxotungstate, PM-19 [J].

Dan, K ;

Yamase, T .

BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (04) :169-173

[12] TI2W10PO407- AND [CPFE(CO)2SN]2W10PO385- - PREPARATION, PROPERTIES, AND STRUCTURE DETERMINATION BY W-183 NMR [J].

DOMAILLE, PJ ;

KNOTH, WH .

INORGANIC CHEMISTRY, 1983, 22 (05) :818-822

[13] HIV-1 protease inhibition potential of functionalized polyoxometalates [J].

Fluetsch, Andreas ;

Schroeder, Thilo ;

Gruetter, Markus G. ;

Patzke, Greta R. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (04) :1162-1166

[14] Polyoxometalate-Based Organic-Inorganic Hybrids as Antitumor Drugs [J].

Fu, Lei ;

Gao, Hanqin ;

Yan, Mei ;

Li, Shouzhu ;

Li, Xinyu ;

Dai, Zhifei ;

Liu, Shaoqin .

SMALL, 2015, 11 (24) :2938-2945

[15] Entry inhibitors and their use in the treatment of HIV-1 infection [J].

Haqqani, Aiman A. ;

Tilton, John C. .

ANTIVIRAL RESEARCH, 2013, 98 (02) :158-170

[16] High-throughput real-time assay based on molecular beacons for HIV-1 integrase 3′-processing reaction [J].

He, Hong-qiu ;

Ma, Xiao-hui ;

Liu, Bin ;

Zhang, Xiao-yi ;

Chen, Wei-zu ;

Wang, Cun-xin ;

Cheng, Shao-hui .

ACTA PHARMACOLOGICA SINICA, 2007, 28 (06) :811-817

[17] HIV-1 entry inhibitors: recent development and clinical use [J].

Henrich, Timothy J. ;

Kuritzkes, Daniel R. .

CURRENT OPINION IN VIROLOGY, 2013, 3 (01) :51-57

[18] A novel small-molecule inhibitor of HIV-1 entry [J].

Heredia, Alonso ;

Latinovic, Olga S. ;

Barbault, Florent ;

de Leeuw, Erik P. H. .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 :5469-5478

[19] Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice [J].

Heredia, Alonso ;

Le, Nhut ;

Gartenhaus, Ronald B. ;

Sausville, Edward ;

Medina-Moreno, Sandra ;

Zapata, Juan C. ;

Davis, Charles ;

Gallo, Robert C. ;

Redfield, Robert R. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (30) :9412-9417

[20] ANTI-HIV-1 ACTIVITY, TOXICITY, AND STABILITY STUDIES OF REPRESENTATIVE STRUCTURAL FAMILIES OF POLYOXOMETALATES [J].

HILL, CL ;

WEEKS, MS ;

SCHINAZI, RF .

JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) :2767-2772

← 1 2 3 4 5 →